Dennis Krieg A. Menarini Research & Service Business GmbH

Dennis is a pharmacist by training and received a Ph.D. for his research in the working group of Prof. Dr. Gerhard Winter at the Ludwig-Maximilians-University Munich. In his thesis, Dennis focused on different aspects of protein co-formulations. The scope of his research included the analytical characterization, formulation development, stability testing and interaction studies of co-formulations for therapeutically relevant cytokines, enzymes and antibodies. In 2020, he joined the A. Menarini Research & Business Service GmbH, where he coordinated the drug product related development activities of multiple internal and external departments and working groups, such as the qualification and validation of analytical methods, formulation and process development as well as stability studies for IMP or final drug product in early and late stage drug product development projects. Starting September 2022, Dennis will work on the process development for RNA-related drug products at the CureVac AG in Tübingen.